First Light Asset Management as of March 31, 2018
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 52 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NeoGenomics (NEO) | 8.5 | $39M | 4.8M | 8.16 | |
| Nektar Therapeutics | 7.0 | $32M | 300k | 106.26 | |
| Array BioPharma | 6.0 | $27M | 1.7M | 16.32 | |
| Harvard Bioscience (HBIO) | 6.0 | $27M | 5.4M | 5.00 | |
| Shire | 5.9 | $27M | 180k | 149.39 | |
| AtriCure (ATRC) | 5.3 | $24M | 1.2M | 20.52 | |
| Tandem Diabetes Care (TNDM) | 5.2 | $24M | 4.7M | 4.96 | |
| Xencor (XNCR) | 4.6 | $21M | 698k | 29.98 | |
| Ligand Pharmaceuticals In (LGND) | 4.2 | $19M | 117k | 165.16 | |
| Model N (MODN) | 4.2 | $19M | 1.1M | 18.05 | |
| Immunomedics | 3.3 | $15M | 1.0M | 14.61 | |
| Omnicell (OMCL) | 3.2 | $15M | 338k | 43.40 | |
| Nevro (NVRO) | 3.2 | $15M | 167k | 86.67 | |
| Heron Therapeutics (HRTX) | 2.9 | $13M | 473k | 27.60 | |
| Cardiovascular Systems | 2.3 | $10M | 470k | 21.93 | |
| Halozyme Therapeutics (HALO) | 2.2 | $9.9M | 503k | 19.59 | |
| Dynavax Technologies (DVAX) | 2.0 | $9.0M | 454k | 19.85 | |
| Globus Med Inc cl a (GMED) | 2.0 | $8.9M | 179k | 49.82 | |
| Oxford Immunotec Global | 1.7 | $7.8M | 627k | 12.45 | |
| Intersect Ent | 1.6 | $7.4M | 189k | 39.30 | |
| Codexis (CDXS) | 1.5 | $7.0M | 634k | 11.00 | |
| Bio-techne Corporation (TECH) | 1.3 | $5.8M | 39k | 151.05 | |
| HealthStream (HSTM) | 1.2 | $5.5M | 222k | 24.83 | |
| Nuvectra | 1.2 | $5.4M | 414k | 13.02 | |
| K2m Group Holdings | 1.1 | $5.2M | 275k | 18.95 | |
| NxStage Medical | 1.1 | $4.8M | 193k | 24.86 | |
| Veracyte (VCYT) | 1.0 | $4.7M | 850k | 5.56 | |
| LHC | 1.0 | $4.4M | 72k | 61.56 | |
| Bluebird Bio | 0.9 | $4.3M | 25k | 170.76 | |
| Quidel Corporation | 0.9 | $3.9M | 76k | 51.81 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $3.8M | 23k | 162.96 | |
| Teligent | 0.8 | $3.7M | 1.1M | 3.36 | |
| Streamline Health Solutions | 0.8 | $3.5M | 1.9M | 1.84 | |
| BioMarin Pharmaceutical (BMRN) | 0.6 | $2.6M | 32k | 81.07 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.5 | $2.3M | 21k | 106.76 | |
| IRIDEX Corporation (IRIX) | 0.5 | $2.2M | 388k | 5.72 | |
| Powershares Etf Tr Ii s^p smcp hc po | 0.4 | $1.9M | 17k | 111.43 | |
| Ionis Pharmaceuticals (IONS) | 0.4 | $1.9M | 43k | 44.08 | |
| Alkermes (ALKS) | 0.4 | $1.8M | 30k | 57.96 | |
| Orthopediatrics Corp. (KIDS) | 0.4 | $1.7M | 116k | 15.06 | |
| LeMaitre Vascular (LMAT) | 0.4 | $1.7M | 47k | 36.24 | |
| Health Care SPDR (XLV) | 0.3 | $1.5M | 18k | 81.41 | |
| iShares Dow Jones US Medical Dev. (IHI) | 0.3 | $1.4M | 7.6k | 184.96 | |
| Enzo Biochem (ENZB) | 0.3 | $1.4M | 251k | 5.48 | |
| Celgene Corporation | 0.3 | $1.2M | 14k | 89.23 | |
| Abbvie (ABBV) | 0.1 | $394k | 4.2k | 94.73 | |
| Pfizer (PFE) | 0.1 | $304k | 8.6k | 35.52 | |
| Dynatronics | 0.1 | $321k | 107k | 3.00 | |
| Johnson & Johnson (JNJ) | 0.1 | $280k | 2.2k | 128.26 | |
| Novartis (NVS) | 0.1 | $289k | 3.6k | 80.91 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $269k | 6.7k | 40.03 | |
| Merck & Co (MRK) | 0.1 | $234k | 4.3k | 54.49 |
